Movers: Wells Fargo, Wachovia, Citigroup, ImClone, eBay

(page 2 of 2)

businessweek.com/research/stocks/snapshot/snapshot.asp?symbol=IRF'>IRF) can, through good faith negotiations, demonstrate to it that a further price increase is justified, VSH would be willing to improve its previous $23.00 per share cash offer for IRF.

Rightnow Technologies (RNOW) says it expects to report negative cash flow from operations primarily due to a lengthening of payment terms and slower cash collections. As a result, the company expects to reduce its full year guidance for cash from operations.

OSI Pharmaceuticals (OSIP) and Genentech (DNA) say randomized Phase III study evaluating Avastin in combination with Tarceva in patients with advanced non-small cell lung cancer whose disease had progressed following platinum-based chemotherapy did not meet its primary endpoint of improving overall survival compared to Tarceva in combination with placebo.

Hartford Financial Services Group (HIG) announces binding a deal with Allianz SE, which provides for a $2.5 billion capital investment. It says Allianz will buy, at $31/share, $750 million of preferred shares convertible to common stock after receipt of applicable approvals, $1.75 billion of 10% junior subordinated debentures. Expects $8.50-$8.80 third quarter loss (including $7.05-$7.25 in net realized cap. losses); $1.50-$1.60 core EPS before effect of a DAC (deferred acquisition costs) unlock.

Mastec (MTZ) to acquire Wanzek Construction for $200 million in cash and the assumption of $15 million in debt. Due to several recent acquisitions, it raises 2008 guidance to $1.375-$1.395 billion revenue, EPS from continuing operations to $0.92-$0.95. Sees 2009 revenue of $1.95-$2.0 billion and EPS of $1.05-$1.15.

Vignette (VIGN) sees lower-than-expected third quarter revenue of $41-$42 million with license revenue of about 17%-19% of total revenue. Notes weak international license sales.